Clínica Médica

OMS atualiza diretrizes de COVID-19 sobre máscaras, tratamentos e cuidados do paciente

16 Jan, 2023 | 11:17h

WHO updates COVID-19 guidelines on masks, treatments and patient care – World Health Organization

Diretrizes OMS atualizadas:

Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023 – World Health Organization

Clinical management of COVID-19: Living guideline, 13 January 2023 – World Health Organization – World Health Organization

Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization

Diretrizes ASA 2023 para jejum pré-operatório

16 Jan, 2023 | 11:15h

2023 American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting: Carbohydrate-containing Clear Liquids with or without Protein, Chewing Gum, and Pediatric Fasting Duration—A Modular Update of the 2017 American Society of Anesthesiologists Practice Guidelines for Preoperative Fasting – Anesthesiology

Estudo de coorte | Eventos adversos identificados em aproximadamente 1 em cada 4 internações hospitalares

16 Jan, 2023 | 11:14h

The Safety of Inpatient Health Care – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Findings from the SafeCare study underscore importance of patient safety, need for continued improvement – Mass General Brigham

Comentário: Nearly 1 in 4 Hospital Patients Have Harmful Event During Their Stay – HealthDay

Comentário no Twitter

A retrospective cohort study assessed patient safety in 11 Massachusetts hospitals in 2018. Adverse events were identified in 24% of hospital admissions and preventable adverse events in 7%. https://t.co/o4JM4JbxSF pic.twitter.com/yPSnvXM5IR

— NEJM (@NEJM) January 13, 2023

Estudo randomizado | Fluvoxamina não é melhor que placebo em pacientes ambulatoriais com COVID-19 leve a moderada

16 Jan, 2023 | 11:12h

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Lack of Benefit of Fluvoxamine for COVID-19 – JAMA

Entrevista com a autora: Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19 – JAMA

Comentário: Trial finds that fluvoxamine doesn’t speed COVID recovery – CIDRAP

Comentário no Twitter

Among outpatients with mild to moderate #COVID19, treatment with 50 mg of fluvoxamine twice daily for 10 days, compared with placebo, did not improve time to sustained recovery. https://t.co/4QgBssqFSU pic.twitter.com/RMZ6mqlx6u

— JAMA (@JAMA_current) January 12, 2023

Melhores artigos de 2022 sobre doenças infecciosas – Uma revisão de fim de ano da literatura não COVID

16 Jan, 2023 | 11:06h

Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature – IDstewardship

Comentário no Twitter

🔥🔥NEW 🔥🔥
Our new post, a great collaboration w 🌟 @IDstewardship
Best Infectious Diseases Articles From 2022 – A Year End Review Of Non-COVID Literature
1️⃣7️⃣⚡️🆔 RCTs @NEJM @TheLancet ✨
2️⃣syst Rev
3️⃣🌏Guidelines @Wiki_Guidelines
#IDTwitter #TwitteRx https://t.co/JL07NLa3BV pic.twitter.com/Qcf2cwK8Sd

— Antibiotic Steward Bassam Ghanem🆔🌟 (@ABsteward) January 4, 2023

M-A | Efeito da respiração sobre o estresse e a saúde mental

16 Jan, 2023 | 11:04h

Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials – Scientific Reports

Comentário: Review and meta-analysis suggests breathwork may be effective for improving stress and mental health – News Medical

Comentário no Twitter

A meta-analysis in @SciReports shows that breathwork may be effective for improving stress and mental health. The authors also call for nuanced research approaches with low risk-of-bias study designs to avoid a miscalibration between hype and evidence. https://t.co/iTLGE2AsPT pic.twitter.com/SM5FBL2idK

— Nature Portfolio (@NaturePortfolio) January 12, 2023